The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 24 August 2004, www.theannals.com, DOI 10.1345/aph.1D509.
The Annals of Pharmacotherapy: Vol. 38, No. 10, pp. 1608-1611. DOI 10.1345/aph.1D509
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trissel, L. A
Right arrow Articles by Xu, Q. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trissel, L. A
Right arrow Articles by Xu, Q. A

ONCOLOGY

Physical and Chemical Stability of Palonosetron HCl in 4 Infusion Solutions

Lawrence A Trissel, BS

Director, Division of Pharmacy Unit 90, University of Texas MD Anderson Cancer Center, Houston, TX

Quanyun A Xu, PhD

Research Scientist, Clinical Pharmaceutics Research, University of Texas MD Anderson Cancer Center

Reprints: Lawrence A Trissel BS, Division of Pharmacy Unit 90, UTMD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4095, fax 713/796-1910

BACKGROUND: Palonosetron HCl is a selective 5-HT3 receptor antagonist used for the prevention of chemotherapy-induced nausea and vomiting. Palonosetron HCl may be diluted in an infusion solution for administraton. Consequently, stability information is needed for palonosetron HCl admixed in common infusion solutions.

OBJECTIVE: To evaluate the physical and chemical stability of palonosetron HCl in concentrations of 5 and 30 µg/mL in dextrose 5% injection, NaCl 0.9% injection, dextrose 5% in NaCl 0.45% injection, and dextrose 5% in lactated Ringer's injection.

METHODS: Triplicate test samples of palonosetron HCl at each concentration in each diluent were tested. Samples were stored and evaluated at appropriate intervals for up to 48 hours at room temperature (~23 °C) and 14 days under refrigeration (4 °C). Physical stability was assessed using turbidimetric and particulate measurement, as well as visual inspection. Chemical stability was assessed by HPLC.

RESULTS: All of the admixtures were initially clear and colorless when viewed in normal fluorescent room light and with a Tyndall beam. Measured turbidity and particulate content were low initially and remained low throughout the study. The drug concentration was unchanged in any of the samples at either temperature throughout the study.

CONCLUSIONS: Palonosetron HCl is physically and chemically stable in all 4 common infusion solutions for at least 48 hours at room temperature and 14 days under refrigeration.

Key Words: compatibility, palonosetron, stability

Published Online, August 24, 2004. www.theannals.com, DOI 10.1345/aph.1D509


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
T. C. Kupie, C. Trusley, M. Ben, and L. A. Trissel
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration
Am. J. Health Syst. Pharm., September 15, 2008; 65(18): 1735 - 1759.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
L. A. Trissel, C. Trusley, M. Ben, and T. C. Kupiec
Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during simulated Y-site administration
Am. J. Health Syst. Pharm., June 1, 2007; 64(11): 1209 - 1213.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.